Kathy Astrahantseff

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Topics

Circulating Tumor

Small Cell Lung Cancer

Top Venues

Communications biology

Nature communications

Journal of enzyme inhibition and medicinal chemistry

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Tatsiana Ryl, Elena Afanasyeva, Till Hartmann, Melanie Schwermer, Markus Schneider, Christopher Schröder, Maren Wagemanns, Arthur Bister, Deniz Kanber, Laura Steenpass, Kathrin Schramm, Barbara Jones, David T W Jones, Eva Biewald, Kathy Astrahantseff, Helmut Hanenberg, Sven Rahmann, Dietmar R Lohmann, Alexander Schramm, Petra Ketteler
Author Correction: A MYCN-driven de-differentiation profile identifies a subgroup of aggressive retinoblastoma. Communications biology 7 (1) (2024)
Tatsiana Ryl, Elena Afanasyeva, Till Hartmann, Melanie Schwermer, Markus Schneider, Christopher Schröder, Maren Wagemanns, Arthur Bister, Deniz Kanber, Laura Steenpass, Kathrin Schramm, Barbara Jones, David T W Jones, Eva Biewald, Kathy Astrahantseff, Helmut Hannenberg, Sven Rahmann, Dietmar R Lohmann, Alexander Schramm, Petra Ketteler
A MYCN-driven de-differentiation profile identifies a subgroup of aggressive retinoblastoma. Communications biology 7 (1) (2024)
Tatsiana Ryl, Elena Afanasyeva, Till Hartmann, Melanie Schwermer, Markus Schneider, Christopher Schröder, Maren Wagemanns, Arthur Bister, Deniz Kanber, Laura Steenpass, Kathrin Schramm, Barbara Jones, David T W Jones, Eva Biewald, Kathy Astrahantseff, Helmut Hannenberg, Sven Rahmann, Dietmar R Lohmann, Alexander Schramm, Petra Ketteler
A MYCN-driven de-differentiation profile identifies a subgroup of aggressive retinoblastoma. Communications biology 7 (1) (2024)
Tatsiana Ryl, Elena Afanasyeva, Till Hartmann, Melanie Schwermer, Markus Schneider, Christopher Schröder, Maren Wagemanns, Arthur Bister, Deniz Kanber, Laura Steenpass, Kathrin Schramm, Barbara Jones, David T W Jones, Eva Biewald, Kathy Astrahantseff, Helmut Hannenberg, Sven Rahmann, Dietmar R Lohmann, Alexander Schramm, Petra Ketteler
A MYCN-driven de-differentiation profile identifies a subgroup of aggressive retinoblastoma. Communications biology 7 (1) (2024)
Steffen Fuchs, Clara Danßmann, Filippos Klironomos, Annika Winkler, Jörg Fallmann, Louisa-Marie Kruetzfeldt, Annabell Krienelke-Szymansky, Julian Naderi, Stephan H Bernhart, Laura Grunewald, Konstantin Helmsauer, Elias Rodriguez-Fos, Marieluise Kirchner, Philipp Mertins, Kathy Astrahantseff, Christin Suenkel, Joern Toedling, Fabienne Meggetto, Marc Remke, Peter F Stadler, Patrick Hundsdoerfer, Hedwig E Deubzer, Annette Künkele, Peter Lang, Jörg Fuchs, Anton G Henssen, Angelika Eggert, Nikolaus Rajewsky, Falk Hertwig, Johannes Hubertus Schulte
Defining the landscape of circular RNAs in neuroblastoma unveils a global suppressive function of MYCN. Nature communications 14 (1) (2023)
Hedwig E Deubzer, Kathy Astrahantseff, Marco Lodrini
A Deep Dive into the Circulating ctDNA Cosmos to Vanquish Neuroblastoma. Cancer discovery 12 (12) (2022)
Karin Schmelz, Joern Toedling, Matthew Huska, Maja C Cwikla, Louisa-Marie Kruetzfeldt, Jutta Proba, Peter F Ambros, Inge M Ambros, Sengül Boral, Marco Lodrini, Celine Y Chen, Martin Burkert, Dennis Guergen, Annabell Krienelke-Szymansky, Kathy Astrahantseff, Annette Kuenkele, Kerstin Haase, Matthias Fischer, Hedwig E Deubzer, Falk Hertwig, Patrick Hundsdoerfer, Anton G Henssen, Roland F Schwarz, Johannes Hubertus Schulte, Angelika Eggert
Spatial and temporal intratumour heterogeneity has potential consequences for single biopsy-based neuroblastoma treatment decisions. Nature communications 12 (1) (2021)
Birte Arlt, Guido Mastrobuoni, Jasmin Wuenschel, Kathy Astrahantseff, Angelika Eggert, Stefan Kempa, Hedwig E Deubzer
Inhibiting PHGDH with NCT-503 reroutes glucose-derived carbons into the TCA cycle, independently of its on-target effect. Journal of enzyme inhibition and medicinal chemistry 36 (1) (2021)